Levodopa-carbidopa intestinal gelin advanced Parkinson's disease: Final 12-month, open-label results. Mov Disord 2015;30:500-9. | USF Parkinson's Disease and Movement Disorders Center

Fernandez, HH, DG Standaert, RA Hauser, AE Lang, VS Fung, F Klostermann, MF Lew, et al. 2015. “Levodopa-Carbidopa Intestinal Gelin Advanced Parkinson’s Disease: Final 12-Month, Open-Label Results. Mov Disord 2015;30:500-9.”. Mov Disord.

Last updated on 10/03/2024